Our findings provide first functional evidence of a reciprocal relationship between ATR and HR repair in BLCA underscoring the potential for therapeutically exploiting this connection, particularly for the rare and therapeutic challenging patient group diagnosed with squamous differentiated tumors. This evidence concerns the gene ATR and bladder transitional cell carcinoma.